Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports
详细信息 查看全文
- 作者：Elena Campione ; Monia Di Prete ; Ilaria Del Principe…
- 关键词：Skin cancer ; Immunomodulant therapy ; Anti ; CD20 monoclonal antibodies
- 刊名：Journal of Medical Case Reports
- 出版年：2016
- 出版时间：December 2016
- 年：2016
- 卷：10
- 期：1
- 全文大小：331 KB
- 刊物主题：Medicine/Public Health, general; General Practice / Family Medicine; Public Health; Primary Care Medicine;
- 出版者：BioMed Central
- ISSN：1752-1947
文摘
Background Non-Hodgkin lymphomas are a heterogeneous group, which involve either B or T lymphocytes. The most used treatment is a chemotherapy regimen, which includes cyclophosphamide, hydroxydaunorubicin, oncovin and prednisone combined with rituximab - a monoclonal antibody specific for CD20 - an antigen expressed on B lymphocyte membrane. Nonmelanoma skin cancers are the most common forms in patients who have lymphomas.